Anna Maria Marzeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Maria Marzeda has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Kim S. Midwood
Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK
5 shared publications Anja Schwenzer
The Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom
3 shared publicationsAdam P. Cribbs
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, Botnar Research Centre, University of Oxford, Oxford, UK
1 shared publicationAlicia Wong
Jagiellonian University, Krakow, Poland
1 shared publication- Amélie M. Julé
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK
1 shared publication - Anja Schwenzer
Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- Open Access
- 10 May 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (9) , 1484-1500
Investigating endogenous immune-mediated monocyte memory in rheumatoid arthritis
- 10 May 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (9) , 1484-1500
Open AccessInvestigating endogenous immune-mediated monocyte memory in rheumatoid arthritis
- 31 January 2018
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 66 (4) , 289-304
Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity
To protect against danger, the innate immune system must promptly and accurately sense alarm signals, and mount an appropriate response to restore homeostasis. One endogenous trigger of immunity is tenascin-C, a large hexameric protein of the extracellular matrix. Upregulated upon tissue injury and cellular stress, tenascin-C is expressed during inflammation and tissue remodeling, where it influences cellular behavior by interacting with a multitude of molecular targets, including other matrix components, cell surface proteins, and growth factors. Here, we discuss how these interactions confer upon tenascin-C distinct immunomodulatory capabilities that make this matrix molecule necessary for efficient tissue repair. We also highlight in vivo studies that provide insight into the consequences of misregulated tenascin-C expression on inflammation and fibrosis during a wide range of inflammatory diseases. Finally, we examine how its unique expression pattern and inflammatory actions make tenascin-C a viable target for clinical exploitation in both diagnostic and therapeutic arenas.
- 31 January 2018
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 66 (4) , 289-304
Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity
To protect against danger, the innate immune system must promptly and accurately sense alarm signals, and mount an appropriate response to restore homeostasis. One endogenous trigger of immunity is tenascin-C, a large hexameric protein of the extracellular matrix. Upregulated upon tissue injury and cellular stress, tenascin-C is expressed during inflammation and tissue remodeling, where it influences cellular behavior by interacting with a multitude of molecular targets, including other matrix components, cell surface proteins, and growth factors. Here, we discuss how these interactions confer upon tenascin-C distinct immunomodulatory capabilities that make this matrix molecule necessary for efficient tissue repair. We also highlight in vivo studies that provide insight into the consequences of misregulated tenascin-C expression on inflammation and fibrosis during a wide range of inflammatory diseases. Finally, we examine how its unique expression pattern and inflammatory actions make tenascin-C a viable target for clinical exploitation in both diagnostic and therapeutic arenas.
- 1 January 2018
- Published by Elsevier
- Vol. 143, 401-428
Investigating cell-type specific functions of tenascin-C
- 1 January 2018
- Published by Elsevier
- Vol. 143, 401-428
Investigating cell-type specific functions of tenascin-C
- Open Access
- 17 November 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-14
Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers
Pattern recognition underpins innate immunity; the accurate identification of danger, including infection, injury, or tumor, is key to an appropriately targeted immune response. Pathogen detection is increasingly well defined mechanistically, but the discrimination of endogenous inflammatory triggers remains unclear. Tenascin-C, a matrix protein induced upon tissue damage and expressed by tumors, activates toll-like receptor 4 (TLR4)-mediated sterile inflammation. Here we map three sites within tenascin-C that directly and cooperatively interact with TLR4. We also identify a conserved inflammatory epitope in related proteins from diverse families, and demonstrate that its presence targets molecules for TLR detection, while its absence enables escape of innate immune surveillance. These data reveal a unique molecular code that defines endogenous proteins as inflammatory stimuli by marking them for recognition by TLRs.
- 17 November 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-14
Open AccessMapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers
Pattern recognition underpins innate immunity; the accurate identification of danger, including infection, injury, or tumor, is key to an appropriately targeted immune response. Pathogen detection is increasingly well defined mechanistically, but the discrimination of endogenous inflammatory triggers remains unclear. Tenascin-C, a matrix protein induced upon tissue damage and expressed by tumors, activates toll-like receptor 4 (TLR4)-mediated sterile inflammation. Here we map three sites within tenascin-C that directly and cooperatively interact with TLR4. We also identify a conserved inflammatory epitope in related proteins from diverse families, and demonstrate that its presence targets molecules for TLR detection, while its absence enables escape of innate immune surveillance. These data reveal a unique molecular code that defines endogenous proteins as inflammatory stimuli by marking them for recognition by TLRs.
- Open Access
- 30 October 2017
- Published by Wiley in Arthritis & Rheumatology
- Vol. 69 (12) , 2303-2313
Association of Distinct Fine Specificities of Anti−Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis
Objective: In addition to the long‐established link with smoking, periodontitis (PD) is a risk factor for rheumatoid arthritis (RA). This study was undertaken to elucidate the mechanism by which PD could induce antibodies to citrullinated peptides (ACPAs), by examining the antibody response to a novel citrullinated peptide of cytokeratin 13 (CK‐13) identified in gingival crevicular fluid (GCF), and comparing the response to 4 other citrullinated peptides in patients with RA who were well‐characterized for PD and smoking.Methods: The citrullinomes of GCF and periodontal tissue from patients with PD were mapped by mass spectrometry. ACPAs of CK13 (cCK13), tenascin‐C (cTNC5), vimentin (cVIM), α‐enolase (CEP‐1), and fibrinogen β (cFIBβ) were examined by enzyme‐linked immunosorbent assay in patients with RA (n = 287) and patients with osteoarthritis (n = 330), and cross‐reactivity was assessed by inhibition assays.Results: A novel citrullinated peptide cCK13‐1 (444TSNASGR‐Cit‐TSDV‐Cit‐RP458) identified in GCF exhibited elevated antibody responses in RA patients (24%). Anti–cCK13‐1 antibody levels correlated with anti–cTNC5 antibody levels, and absorption experiments confirmed this was not due to cross‐reactivity. Only anti–cCK13‐1 and anti‐cTNC5 were associated with antibodies to the periodontal pathogen Prevotella intermedia (P = 0.05 and P = 0.001, respectively), but not with antibodies to Porphyromonas gingivalis arginine gingipains. Levels of antibodies to CEP‐1, cFIBβ, and cVIM correlated with each other, and with smoking and shared epitope risk factors in RA.Conclusion: This study identifies 2 groups of ACPA fine specificities associated with different RA risk factors. One is predominantly linked to smoking and shared epitope, and the other links anti–cTNC5 and cCK13‐1 to infection with the periodontal pathogen P intermedia.
- 30 October 2017
- Published by Wiley in Arthritis & Rheumatology
- Vol. 69 (12) , 2303-2313
Open AccessAssociation of Distinct Fine Specificities of Anti−Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis
Objective: In addition to the long‐established link with smoking, periodontitis (PD) is a risk factor for rheumatoid arthritis (RA). This study was undertaken to elucidate the mechanism by which PD could induce antibodies to citrullinated peptides (ACPAs), by examining the antibody response to a novel citrullinated peptide of cytokeratin 13 (CK‐13) identified in gingival crevicular fluid (GCF), and comparing the response to 4 other citrullinated peptides in patients with RA who were well‐characterized for PD and smoking.Methods: The citrullinomes of GCF and periodontal tissue from patients with PD were mapped by mass spectrometry. ACPAs of CK13 (cCK13), tenascin‐C (cTNC5), vimentin (cVIM), α‐enolase (CEP‐1), and fibrinogen β (cFIBβ) were examined by enzyme‐linked immunosorbent assay in patients with RA (n = 287) and patients with osteoarthritis (n = 330), and cross‐reactivity was assessed by inhibition assays.Results: A novel citrullinated peptide cCK13‐1 (444TSNASGR‐Cit‐TSDV‐Cit‐RP458) identified in GCF exhibited elevated antibody responses in RA patients (24%). Anti–cCK13‐1 antibody levels correlated with anti–cTNC5 antibody levels, and absorption experiments confirmed this was not due to cross‐reactivity. Only anti–cCK13‐1 and anti‐cTNC5 were associated with antibodies to the periodontal pathogen Prevotella intermedia (P = 0.05 and P = 0.001, respectively), but not with antibodies to Porphyromonas gingivalis arginine gingipains. Levels of antibodies to CEP‐1, cFIBβ, and cVIM correlated with each other, and with smoking and shared epitope risk factors in RA.Conclusion: This study identifies 2 groups of ACPA fine specificities associated with different RA risk factors. One is predominantly linked to smoking and shared epitope, and the other links anti–cTNC5 and cCK13‐1 to infection with the periodontal pathogen P intermedia.
- 1 February 2017
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (6) , 896-902
Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels
The pentraxin serum amyloid P component (SAP) is secreted by the liver and found in plasma at a concentration of approximately 30 mg/L. SAP is a 25 kDa homopentamer known to bind both protein and nonprotein ligands, all in a calcium-dependent manner. The function of SAP is unclear but likely involves the humoral innate immune system spanning the complement system, inflammation, and coagulation. Also, SAP is known to bind to the generic structure of amyloid deposits and possibly to protect them against proteolysis. In this study, we have characterized the SAP interactome in human plasma containing the physiological Ca2+ concentration using SAP affinity pull-down and co-immunoprecipitation experiments followed by mass spectrometry analyses. The analyses resulted in the identification of 33 proteins, of which 24 were direct or indirect interaction partners not previously reported. The SAP interactome can be divided into categories that include apolipoproteins, the complement system, coagulation, and proteolytic regulation.
- 1 February 2017
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 56 (6) , 896-902
Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels
The pentraxin serum amyloid P component (SAP) is secreted by the liver and found in plasma at a concentration of approximately 30 mg/L. SAP is a 25 kDa homopentamer known to bind both protein and nonprotein ligands, all in a calcium-dependent manner. The function of SAP is unclear but likely involves the humoral innate immune system spanning the complement system, inflammation, and coagulation. Also, SAP is known to bind to the generic structure of amyloid deposits and possibly to protect them against proteolysis. In this study, we have characterized the SAP interactome in human plasma containing the physiological Ca2+ concentration using SAP affinity pull-down and co-immunoprecipitation experiments followed by mass spectrometry analyses. The analyses resulted in the identification of 33 proteins, of which 24 were direct or indirect interaction partners not previously reported. The SAP interactome can be divided into categories that include apolipoproteins, the complement system, coagulation, and proteolytic regulation.